Coronavirus Trend Helps Improve Krka’s EBIT By 85%

As Prescription Pharmaceutical Sales Shoot Up In Q1

 
• By Dean Rudge
  
Arrow
Krka saw a huge upward tick for its EBIT during the first quarter of this year • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business